We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+1.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.54B
AUM Growth
-$175M
(-2.3%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
2,467
New
22
Increased
509
Reduced
1,757
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$26.2M |
| 2 |
Microsoft
MSFT
|
+$22.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$17.2M |
| 4 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 5 |
Intel
INTC
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$8.87M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$7.51M |
| 3 |
Wells Fargo
WFC
|
+$6.77M |
| 4 |
JPMorgan Chase
JPM
|
+$6.34M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$5.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Financials | 16.41% |
| 3 | Healthcare | 13.76% |
| 4 | Industrials | 8.56% |
| 5 | Consumer Discretionary | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CXO
1101
DELISTED
CONCHO RESOURCES INC.
CXO
| $919K | 0.01% |
7,331
-1,244
| -15% | -$170K |
|
1102
Healthcare Services Group
HCSG
$1.56B
| $915K | 0.01% |
31,970
-7,791
| -20% | -$217K |
|
|
AIRM
1103
DELISTED
Air Methods Corp
AIRM
| $915K | 0.01% |
16,472
-4,017
| -20% | -$221K |
|
1104
Ligand Pharmaceuticals
LGND
$6.02B
| $913K | 0.01% |
31,148
-6,540
| -17% | -$217K |
|
|
PTLA
1105
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $909K | 0.01% |
35,976
-6,963
| -16% | -$183K |
|
|
UIL
1106
DELISTED
UIL HOLDINGS
UIL
| $908K | 0.01% |
25,652
-6,366
| -20% | -$233K |
|
1107
Novavax
NVAX
$1.23B
| $907K | 0.01% |
10,871
-581
| -5% | -$52.5K |
|
1108
TD Synnex
SNX
$19.4B
| $907K | 0.01% |
28,062
-5,752
| -17% | -$189K |
|
|
SKX
1109
DELISTED
Skechers
SKX
| $901K | 0.01% |
50,724
-10,983
| -18% | -$201K |
|
|
AEGR
1110
DELISTED
Aegerion Pharmaceuticals
AEGR
| $899K | 0.01% |
26,937
-6,285
| -19% | -$195K |
|
|
ASNA
1111
DELISTED
Ascena Retail Group, Inc.
ASNA
| $896K | 0.01% |
3,368
+426
| +14% | +$140K |
|
1112
Acadia Healthcare
ACHC
$3.17B
| $894K | 0.01% |
18,443
+722
| +4% | +$35.3K |
|
1113
Fossil Group
FOSL
$239M
| $890K | 0.01% |
9,477
-5,109
| -35% | -$515K |
|
|
MDC
1114
DELISTED
M.D.C. Holdings, Inc.
MDC
| $888K | 0.01% |
48,708
-1,886
| -4% | -$38.2K |
|
|
AMSG
1115
DELISTED
Amsurg Corp
AMSG
| $887K | 0.01% |
17,732
+393
| +2% | +$19.6K |
|
1116
AXIS Capital
AXS
$8.59B
| $884K | 0.01% |
18,672
-1,077
| -5% | -$49.8K |
|
|
ACHN
1117
DELISTED
Achillion Pharmaceuticals
ACHN
| $883K | 0.01% |
88,487
-16,997
| -16% | -$158K |
|
|
PPO
1118
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $880K | 0.01% |
22,613
-5,494
| -20% | -$240K |
|
1119
Sanmina
SANM
$11.2B
| $874K | 0.01% |
41,918
-8,322
| -17% | -$194K |
|
|
ARIA
1120
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $874K | 0.01% |
161,840
-39,098
| -19% | -$228K |
|
1121
Altisource Portfolio Solutions
ASPS
$65.4M
| $870K | 0.01% |
1,078
-206
| -16% | -$168K |
|
1122
CACI
CACI
$10.8B
| $865K | 0.01% |
12,134
-2,459
| -17% | -$173K |
|
|
DGI
1123
DELISTED
DigitalGlobe Inc.
DGI
| $863K | 0.01% |
30,296
-6,940
| -19% | -$202K |
|
1124
Cracker Barrel
CBRL
$1.2B
| $862K | 0.01% |
8,351
-2,061
| -20% | -$206K |
|
1125
Iron Mountain
IRM
$38.2B
| $856K | 0.01% |
26,203
-4,458
| -15% | -$145K |
|
Similar funds
ProShare Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, ProShare Advisors held 2,467 positions worth $7.54B, down 2.3% from $7.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors's Q3 2014 filing shows 22 new, 509 increased, 1,757 reduced and 175 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 80,042 shares worth $2.98M. The largest sale was ExxonMobil, an estimated $8.87M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- ProShare Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 80,042 shares worth $2.98M.
- ProShare Advisors added most to Apple in Q3 2014, an estimated $26.2M increase.
- ProShare Advisors's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $8.87M.
- ProShare Advisors fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $5.81M.
- ProShare Advisors's ten largest holdings make up 16% of its $7.54B portfolio in Q3 2014.
- ProShare Advisors opened 22 new positions and closed 175 in Q3 2014.
- ProShare Advisors's portfolio value fell 2.3% quarter-over-quarter to $7.54B.
Based on ProShare Advisors's 13F filing for Q3 2014, filed 6 Nov 2014.